All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Teva Pharmaceutical Industries Limited revenue reports

Teva Pharmaceutical Industries Limited financial reports, Teva Pharmaceutical Industries Limited annual revenue in 2024. When does Teva Pharmaceutical Industries Limited report revenue?
Add to widgets
Added to widgets

Teva Pharmaceutical Industries Limited total revenue, net income and dynamics of changes in Mexican peso today

Teva Pharmaceutical Industries Limited revenue for the past few reporting periods. Net income Teva Pharmaceutical Industries Limited - 207 000 000 $. Information about net income is used from open sources. The dynamics of Teva Pharmaceutical Industries Limited net income grew by 130 000 000 $ for the last reporting period. The financial schedule of Teva Pharmaceutical Industries Limited consists of three charts of the main financial indicators of the company: total assets, net revenue, net income. The value of "net income" Teva Pharmaceutical Industries Limited on the graph is displayed in blue. A graph of the value of all Teva Pharmaceutical Industries Limited assets is presented in green bars.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
30/06/2021 67 095 991 000 $ -9.846 % ↓ 3 552 140 700 $ -
31/03/2021 68 331 518 200 $ -7.288 % ↓ 1 321 327 700 $ -
31/12/2020 76 413 925 300 $ +11.58 % ↑ 2 574 015 000 $ +37.61 % ↑
30/09/2020 68 262 877 800 $ -6.7073 % ↓ -74 629 274 900 $ -
31/12/2019 68 485 959 100 $ - 1 870 450 900 $ -
30/09/2019 73 170 666 400 $ - -5 388 271 400 $ -
30/06/2019 74 423 353 700 $ - -11 823 308 900 $ -
31/03/2019 73 702 629 500 $ - -1 801 810 500 $ -
Show:
to

Teva Pharmaceutical Industries Limited financial report charts

The latest dates of Teva Pharmaceutical Industries Limited financial statements available online: 31/03/2019, 31/03/2021, 30/06/2021. The dates of the financial statements are determined by the accounting rules. The latest financial report of Teva Pharmaceutical Industries Limited is available online for such a date - 30/06/2021. Gross profit Teva Pharmaceutical Industries Limited is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Teva Pharmaceutical Industries Limited is 1 873 000 000 $

Teva Pharmaceutical Industries Limited quarterly report dates

Cost of revenue Teva Pharmaceutical Industries Limited is the total cost of producing and distributing of products and services of a company. Cost of revenue Teva Pharmaceutical Industries Limited is 2 037 000 000 $ Total revenue Teva Pharmaceutical Industries Limited refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Teva Pharmaceutical Industries Limited is 3 910 000 000 $ Operating income Teva Pharmaceutical Industries Limited is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Teva Pharmaceutical Industries Limited is 783 000 000 $

Net income Teva Pharmaceutical Industries Limited is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Teva Pharmaceutical Industries Limited is 207 000 000 $ Current assets Teva Pharmaceutical Industries Limited is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Teva Pharmaceutical Industries Limited is 12 822 000 000 $ Total assets Teva Pharmaceutical Industries Limited refers to the total amount of assets owned by a person or entity. Total assets Teva Pharmaceutical Industries Limited is 49 195 000 000 $

30/06/2021 31/03/2021 31/12/2020 30/09/2020 31/12/2019 30/09/2019 30/06/2019 31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
32 140 867 300 $ 32 226 667 800 $ 35 143 884 800 $ 31 780 505 200 $ 33 599 475 800 $ 31 385 822 900 $ 32 501 229 400 $ 31 831 985 500 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
34 955 123 700 $ 36 104 850 400 $ 41 270 040 500 $ 36 482 372 600 $ 34 886 483 300 $ 41 784 843 500 $ 41 922 124 300 $ 41 870 644 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
67 095 991 000 $ 68 331 518 200 $ 76 413 925 300 $ 68 262 877 800 $ 68 485 959 100 $ 73 170 666 400 $ 74 423 353 700 $ 73 702 629 500 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - - - - - -
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
13 436 358 300 $ 12 852 914 900 $ 12 389 592 200 $ 12 046 390 200 $ 12 012 070 000 $ 11 960 589 700 $ 11 651 707 900 $ 11 016 784 200 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
3 552 140 700 $ 1 321 327 700 $ 2 574 015 000 $ -74 629 274 900 $ 1 870 450 900 $ -5 388 271 400 $ -11 823 308 900 $ -1 801 810 500 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
4 255 704 800 $ 4 358 665 400 $ 5 027 909 300 $ 4 427 305 800 $ 3 981 143 200 $ 4 118 424 000 $ 4 736 187 600 $ 4 478 786 100 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
53 659 632 700 $ 55 478 603 300 $ 64 024 333 100 $ 56 216 487 600 $ 56 473 889 100 $ 61 210 076 700 $ 62 771 645 800 $ 62 685 845 300 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
220 026 802 200 $ 212 802 400 100 $ 223 167 100 500 $ 208 666 816 000 $ 231 043 586 400 $ 215 221 974 200 $ 236 895 180 500 $ 230 494 463 200 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
844 191 119 500 $ 840 913 540 400 $ 868 987 464 000 $ 853 491 893 700 $ 986 190 947 000 $ 982 347 084 600 $ 1 019 721 782 400 $ 1 027 100 625 400 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
41 802 003 600 $ 29 910 054 300 $ 37 357 537 700 $ 31 351 502 700 $ 33 891 197 500 $ 21 295 684 100 $ 37 151 616 500 $ 33 856 877 300 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
- - - - 234 647 207 400 $ 242 077 530 700 $ 247 997 765 200 $ 240 721 882 800 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - - - -
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
- - - - 727 708 360 700 $ 726 249 752 200 $ 758 030 257 400 $ 755 610 683 300 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
- - - - 73.79 % 73.93 % 74.34 % 73.57 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
177 160 872 400 $ 171 601 000 000 $ 172 047 162 600 $ 164 616 839 300 $ 239 760 917 200 $ 236 637 779 000 $ 242 334 932 200 $ 252 802 593 200 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
- - - - 9 232 133 800 $ 5 577 032 500 $ -3 895 342 700 $ 1 921 931 200 $

Last revenue report of Teva Pharmaceutical Industries Limited was 30/06/2021. According to last financial report total revenue in Teva Pharmaceutical Industries Limited was 67 095 991 000 Mexican peso and changed by -9.846% since last year. Net income in Teva Pharmaceutical Industries Limited was 3 552 140 700 $ in last quartal, net income changes to +37.61%.

Current cash Teva Pharmaceutical Industries Limited - the sum of all of the cash a company has on the date of report. Current cash Teva Pharmaceutical Industries Limited is 2 436 000 000 $

Teva Pharmaceutical Industries Limited stocks data

Teva Pharmaceutical Industries Limited financials